Fundraising Fox
🦊/Companies
Sign in

Alcyonetx

Acquired

1 known investors

Find your way into Alcyonetx

Biogen develops and markets therapies for spinal muscular atrophy (SMA), including FDA-approved treatments and the investigational ThecaFlex DRx System, an implantable intrathecal drug delivery device. The company serves patients and families affected by SMA and other neuromuscular conditions globally.

BiotechDigital HealthHealthtechMedical Devices

Investors · 1

Harbor Light Capital PartnersKeene · $1M – $5M

Frequently asked questions

What does Alcyonetx do?
Biogen develops and markets therapies for spinal muscular atrophy (SMA), including FDA-approved treatments and the investigational ThecaFlex DRx System, an implantable intrathecal drug delivery device. The company serves patients and families affected by SMA and other neuromuscular conditions globally.
Who are Alcyonetx's investors?
Alcyonetx's investors include Harbor Light Capital Partners.